Association of anemia and iron parameters with mortality among prevalent peritoneal dialysis patients in Taiwan: the AIM-PD study

In 1996, the National Health Insurance Administration of Taiwan applied a restrictive reimbursement criteria for erythropoiesis-stimulating agents (ESAs) use in patients with chronic kidney disease. The maximal ESAs dosage allowed by insurance is capped at 20,000 U of epoetin per month. Nephrologist...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuo, Ko-Lin, Liu, Jia-Sin, Lin, Ming-Huang, Hsu, Chih-Cheng, Tarng, Der-Cherng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786856/
https://www.ncbi.nlm.nih.gov/pubmed/35075212
http://dx.doi.org/10.1038/s41598-022-05200-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786856/
https://www.ncbi.nlm.nih.gov/pubmed/35075212
http://dx.doi.org/10.1038/s41598-022-05200-3

Ejemplares similares